1,721,027 research outputs found
Supplemental material for Outcome after intravenous thrombolysis in patients with acute lacunar stroke: An observational study based on SITS international registry and a meta-analysis
No full textSupplemental Material for Outcome after intravenous thrombolysis in patients with acute lacunar stroke: An observational study based on SITS international registry and a meta-analysis by Marius Matusevicius, Maurizio Paciaroni, Valeria Caso, Matteo Bottai, Dheeraj Khurana, Mario de Bastos, Sheila CO Martins, Yakup Krespi, Charith Cooray, Danilo Toni and Niaz Ahmed in International Journal of Stroke</p
In this issue of <i>PLOS Genetics</i>, Hancock et al. address gene–environment interaction effects based on smoking status, GWAS data, and lung function outcomes in over 50,000 adults.
No full text<p>This Perspective highlights the main findings in Hancock et al. <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003174#pgen.1003174-Hancock1" target="_blank">[11]</a> and discusses why interaction effects are so difficult to identify even in large, well-characterized data sets.</p
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
International Classification of Diseases (ICD) codes for cancer death according to calendar period of study.
No full text<p>ICD-7, -8, -9, and -10, International Classification of Diseases, 7<sup>th</sup>, 8<sup>th</sup>, 9<sup>th</sup>, and 10<sup>th</sup> revisions.</p
All-site cancer mortality rate ratio (MRR)<sup>*</sup> and 95% confidence interval (CI) among foreign-born men by continent, region, and country of birth compared with Sweden-born men, 1961–2009.
No full text<p>??? Adjusted for age at follow-up and calendar period at baseline. <sup>a</sup>The former Czechoslovakia includes Czechoslovakia, Slovakia, and the Czech Republic. <sup>b</sup>The former Soviet Union includes Belarus, Moldova, Russian Federation, Soviet Union, and Ukraine. <sup>c</sup>The former Yugoslavia includes Yugoslavia, Croatia, Macedonia, Serbia, Slovenia, and Montenegro.</p
Cancer mortality rate ratio (MRR) and 95% confidence interval (CI) in women by continent, region, and country of birth and cancer type in Sweden, 1961–2009.
No full text<p>*Mortality rate ratios (MRRs) are adjusted for age at follow-up and calendar period at baseline. The reference group is Sweden-born women.</p><p>**Continents, regions, and countries with at least five cases of cancer mortality.</p>a<p>The former Czechoslovakia includes Czechoslovakia, Slovakia, and the Czech Republic.</p>b<p>The former Soviet Union includes Belarus, Moldova, Russian Federation, Soviet Union, and Ukraine.</p>c<p>The former Yugoslavia includes Yugoslavia, Croatia, Macedonia, Serbia, Slovenia, and Montenegro.</p
Age-standardized rate (ASR)* of all-site cancer mortality by sex, education level, and country of birth in Sweden, 1961–2009.
No full text<p>*Only individuals who were ≥30 years old are included.</p
All-site cancer mortality rate ratio (MRR) and 95% confidence interval (CI) by country of birth, sex, and years of education in Sweden, 1961–2009.
No full text<p>*MRR values significantly different from 1.0 are highlighted in bold.</p><p>** Only individuals ≥30 years old are included and MRRs are adjusted for age at follow-up and calendar period at baseline.</p
Age-standardized rate (ASR) of all-site cancer mortality by sex, calendar period of follow-up, and country of birth in Sweden, 1961–2009.
No full text<p>Age-standardized rate (ASR) of all-site cancer mortality by sex, calendar period of follow-up, and country of birth in Sweden, 1961–2009.</p
- …
